Cryofocus Medtech (Shanghai) Balance Sheet Health
Financial Health criteria checks 3/6
Cryofocus Medtech (Shanghai) has a total shareholder equity of CN¥126.0M and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 15.9%. Its total assets and total liabilities are CN¥184.6M and CN¥58.6M respectively.
Key information
15.9%
Debt to equity ratio
CN¥20.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥69.56m |
| Equity | CN¥126.03m |
| Total liabilities | CN¥58.62m |
| Total assets | CN¥184.65m |
Recent financial health updates
Is Cryofocus Medtech (Shanghai) (HKG:6922) Using Too Much Debt?
Sep 02
We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate
Jan 10Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans
Oct 03Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth
May 30Recent updates
Is Cryofocus Medtech (Shanghai) (HKG:6922) Using Too Much Debt?
Sep 02We're Not Very Worried About Cryofocus Medtech (Shanghai)'s (HKG:6922) Cash Burn Rate
Jan 10Cryofocus Medtech (Shanghai) (HKG:6922) Is In A Good Position To Deliver On Growth Plans
Oct 03Companies Like Cryofocus Medtech (Shanghai) (HKG:6922) Are In A Position To Invest In Growth
May 30Financial Position Analysis
Short Term Liabilities: 6922's short term assets (CN¥116.7M) exceed its short term liabilities (CN¥46.1M).
Long Term Liabilities: 6922's short term assets (CN¥116.7M) exceed its long term liabilities (CN¥12.5M).
Debt to Equity History and Analysis
Debt Level: 6922 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 6922's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 6922 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 6922 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 20.8% each year